ISAP Training Program in Addiction Health Services Research This application is for the renewal (Years 21-25) of the pre- and postdoctoral training program at the Integrated Substance Abuse Programs (ISAP) in the Department of Psychiatry and Biobehavioral Sciences, Geffen School of Medicine at UCLA. The ISAP Training Program in Addiction Health Services Research takes advantage of the depth of addiction-related resources at UCLA, and especially the concentration of addiction researchers at ISAP, to provide a comprehensive training program in fundamental addiction research, with a specialized focus on treatment interventions, longitudinal research, and addiction health services. Specific goals of the planned 2-year training program are to equip researchers with the skills needed to undertake research of the highest quality on: (1) the organization and delivery of drug treatment services, including integration with mental health, primary care, and other health and social services; (2) workforce issues, organizational development, and implementation research; (3) economics and financing of drug treatment services; (4) criminal justice systems and treatment interventions for offenders; (5) longitudinal drug use and health and recovery outcomes; and (6) treatment/service use among women, racial/ethnic groups, impoverished/homeless individuals, youth and older adults, and individuals with or affected by HIV/AIDS. Addiction health services researchers are needed who are equipped with the conceptual models, research methodologies, and analytic skills to undertake scientific research to evaluate changes in the organization, delivery, and outcomes of treatment and other services for individuals with substance use disorders within the broader context of the changing health services system. The ISAP training program will focus on this area of research, with the goal of addressing the need for a new generation of addiction health services researchers. Since 1991, the ISAP training program has trained a total of 30 predoctoral and 50 postdoctoral trainees; trainees have an excellent record of employment and productivity in addiction and related research. The program will continue to train 2 predoctoral and 3 postdoctoral fellows per year. The program is guided by an Executive Committee (Grella, Hser, Murphy, and Farabee); trainees have access to 4 Senior Mentors (Rawson, Ling, Shoptaw, and Anglin) as well as 23 other Resource Faculty located in the UCLA Schools of Medicine, Dentistry, Nursing, and Public Affairs. Trainees participate in a 2-year ISAP core curriculum as well as additional coursework, training activities in professional and career development, and ongoing research activities under the guidance of a team of mentors. Trainees are also linked with a wide range of resources at UCLA related to addiction research, training, and professional development. Trainee progress is evaluated on an ongoing basis by the Executive Committee, and corrective actions proposed as needed. In the upcoming funding period, a plan for soliciting external input for evaluating the ISAP training program is proposed.
Within the context of significant changes in public health policy related to the delivery of health services, it is imperative that addiction health services researchers are equipped with the skills needed to undertake research in this area. The ISAP Training Program in Addiction Health Services Research will provide training for pre- and postdoctoral trainees in the conceptual models, research methodologies, and analytic skills needed to undertake addiction health services research. Such research is needed to inform public health policy on the organization, delivery, and outcomes of treatment and other services for individuals with substance use disorders within the context of the broader health services system. The ISAP training program will address the need for a new generation of addiction health services researchers who are trained to conduct research in this area.
|Calhoun, Stacy (2018) The clinician-patient working alliance: Is it a significant predictor of psychiatric medication adherence in a sample of recently released parolees? J Forens Psychiatry Psychol 29:782-793|
|Kim, Seungyoun; Spilman, Samantha L; Liao, Diana H et al. (2018) Social networks and alcohol use among older adults: a comparison with middle-aged adults. Aging Ment Health 22:550-557|
|Kim, Seungyoun; Knight, Bob G (2018) Caregiving Subgroups Differences in the Associations Between the Resilience Resources and Life Satisfaction. J Appl Gerontol 37:1540-1563|
|Park, Alayna L; Moskowitz, Andrew L; Chorpita, Bruce F (2018) Community-Based Providers' Selection of Practices for Children and Adolescents With Comorbid Mental Health Problems. J Clin Child Adolesc Psychol 47:796-807|
|Ijadi-Maghsoodi, Roya; Bath, Eraka; Cook, Mekeila et al. (2018) Commercially sexually exploited youths' health care experiences, barriers, and recommendations: A qualitative analysis. Child Abuse Negl 76:334-341|
|Cook, Mekeila C; Barnert, Elizabeth; Ijadi-Maghsoodi, Roya et al. (2018) Exploring Mental Health and Substance use Treatment Needs of Commercially Sexually Exploited Youth Participating in a Specialty Juvenile Court. Behav Med 44:242-249|
|Lim, Aaron C; Courtney, Kelly E; Moallem, Nathasha R et al. (2018) A Brief Smoking Cessation Intervention for Heavy Drinking Smokers: Treatment Feasibility and Acceptability. Front Psychiatry 9:362|
|Verissimo, Angie Denisse Otiniano; Grella, Christine E (2017) Influence of gender and race/ethnicity on perceived barriers to help-seeking for alcohol or drug problems. J Subst Abuse Treat 75:54-61|
|Tol, Wietse A; Greene, M Claire; Likindikoki, Samuel et al. (2017) An integrated intervention to reduce intimate partner violence and psychological distress with refugees in low-resource settings: study protocol for the Nguvu cluster randomized trial. BMC Psychiatry 17:186|
|Hser, Yih-Ing; Huang, David; Saxon, Andrew J et al. (2017) Distinctive Trajectories of Opioid Use Over an Extended Follow-up of Patients in a Multisite Trial on Buprenorphine?+?Naloxone and Methadone. J Addict Med 11:63-69|
Showing the most recent 10 out of 97 publications